from Stocks-Markets-Economic Times https://ift.tt/2YO2oj0
Home »
Stocks-Markets-Economic Times
» Brokerages’ views mixed on Glenmark Pharma
Brokerages’ views mixed on Glenmark Pharma
from Stocks-Markets-Economic Times https://ift.tt/2YO2oj0
Related Posts:
Dixon Tech Q2 results: Net profit up 19.6% to Rs 63 croreRevenue from operations climbed 71.09 per cent to Rs 2,803.78 crore as against Rs 1,638.74 crore in the year-ago period. from Stocks-Markets-Economic Times https://ift.tt/2XXZDxX … Read More
REC Q2 results: Net profit up 2% to Rs 2,692 crThe power sector NBFC had clocked a net profit of Rs 2,197.14 crore in the quarter ended September 30, 2020, it said in a BSE filing. from Stocks-Markets-Economic Times https://ift.tt/3vYJ3dT … Read More
NSE-BSE bulk deals: Norges Bank sells stake in Srei Infra FinanceIn another transaction, Davos International Fund sold 125,438 shares of Kavveri Telecom Products at Rs. 6.25 apiece through a bulk deal on the NSE. from Stocks-Markets-Economic Times https://ift.tt/3nFgcaH … Read More
Sify Tech Q2 results: Co clocks 18% revenue growthThe company's Ebitda increased by 24 per cent to Rs 1477 million. Profit after tax was Rs 356 million, an increase of 39 per cent over the same quarter last year. from Stocks-Markets-Economic Times https://ift.tt/3mrdoyL … Read More
Equitas SFB Q2 results: Net profit falls 60% to Rs 41 crThe bank's operating profit fell 7.6 per cent at Rs 195 crore as against Rs 211 crore over the same period. Provision was 84 per cent higher at 138 crore compared with Rs 75 crore earlier. from Stocks-Markets-Economic Times … Read More
0 Comments:
Post a Comment